GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yantai Dongcheng Biochemicals Co Ltd (SZSE:002675) » Definitions » EBIT

Yantai Dongcheng Biochemicals Co (SZSE:002675) EBIT : ¥316 Mil (TTM As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Yantai Dongcheng Biochemicals Co EBIT?

Yantai Dongcheng Biochemicals Co's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2024 was ¥33 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was ¥316 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Yantai Dongcheng Biochemicals Co's annualized ROC % for the quarter that ended in Dec. 2024 was -14.43%. Yantai Dongcheng Biochemicals Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 4.82%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Yantai Dongcheng Biochemicals Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 2.62%.


Yantai Dongcheng Biochemicals Co EBIT Historical Data

The historical data trend for Yantai Dongcheng Biochemicals Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yantai Dongcheng Biochemicals Co EBIT Chart

Yantai Dongcheng Biochemicals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 659.17 412.55 504.22 381.60 315.61

Yantai Dongcheng Biochemicals Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -63.12 98.83 80.52 102.91 33.34

Competitive Comparison of Yantai Dongcheng Biochemicals Co's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Yantai Dongcheng Biochemicals Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yantai Dongcheng Biochemicals Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yantai Dongcheng Biochemicals Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Yantai Dongcheng Biochemicals Co's EV-to-EBIT falls into.


;
;

Yantai Dongcheng Biochemicals Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥316 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yantai Dongcheng Biochemicals Co  (SZSE:002675) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Yantai Dongcheng Biochemicals Co's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=442.268 * ( 1 - 318.59% )/( (6683.92 + 6715.723)/ 2 )
=-966.7536212/6699.8215
=-14.43 %

where

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=8643.91 - 1004.794 - ( 955.196 - max(0, 1662.584 - 2633.125+955.196))
=6683.92

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=8634.678 - 1105.262 - ( 904.514 - max(0, 1753.956 - 2567.649+904.514))
=6715.723

Note: The Operating Income data used here is four times the quarterly (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Yantai Dongcheng Biochemicals Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=133.372/( ( (2289.058 + max(509.818, 0)) + (2334.898 + max(395.735, 0)) )/ 2 )
=133.372/( ( 2798.876 + 2730.633 )/ 2 )
=133.372/2764.7545
=4.82 %

where Working Capital is:

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(929.19 + 635.73 + 76.175) - (1004.794 + 0 + 126.483)
=509.818

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(912.413 + 646.221 + 68.19) - (1105.262 + 0 + 125.827)
=395.735

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Yantai Dongcheng Biochemicals Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=315.612/12034.881
=2.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yantai Dongcheng Biochemicals Co EBIT Related Terms

Thank you for viewing the detailed overview of Yantai Dongcheng Biochemicals Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Yantai Dongcheng Biochemicals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 7 ChangBaishan Road, Yan Tai Development Zone, ShanDong, CHN, 264006
Yantai Dongcheng Biochemicals Co Ltd is a biochemical analytical profile index (API) manufacturers in China. In addition, the company also focuses on the development of finished preparation which covers the therapeutic area of cardiovascular, oncology, orthopedics, and anti-infection. Its product offering includes heparin sodium, chondroitin sulfate, marine collagen, hyaluronic acid, glucosamine, heparinoids, and cytochrome C. The company's API products have been exported to more than fifty countries and regions, including the United States of America, Germany, Austria, and Japan.
Executives
Xin Hong Bo Directors, executives
Luo Zhi Gang Executives
You Shou Yi Directors, executives
Lv Chun Xiang Supervisors
Sun Hong Tao Supervisors
Yi Qiong Executives
Yang Zhen Qiu Executives
Bai Xing Hua Directors, executives
Song Zhao Long Supervisors
Wen Lei Director
Zhu Chun Ping Executives
Qi Dong Qi Directors, executives
Liu Xiao Jie Securities Affairs Representative
Wang En Zheng Independent director
Shi Tao Supervisors

Yantai Dongcheng Biochemicals Co Headlines

No Headlines